secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K/A
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001104659-24-058866
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunogenX reports net loss of $8.86M in 2023; auditor cites going concern doubts
--------------------------------------------------------------------------------

- Net loss for 2023 was $8.86M, compared to $3.62M in 2022 and $1.66M in 2021.
- Total assets of $4.1M vs. total liabilities of $18.33M as of Dec 31, 2023, resulting in stockholders' deficit of $14.23M.
- Cash and cash equivalents only $251k as of Dec 31, 2023; auditor expressed substantial doubt about going concern.
- Pre-revenue clinical-stage biotherapeutics company focused on celiac disease treatments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924058866/0001104659-24-058866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924058866/tm2413822d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-058866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer